Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
297.05
+5.99 (2.06%)
Jun 27, 2025, 4:00 PM - Market closed
Molina Healthcare Stock Forecast
Stock Price Forecast
According to 16 professional analysts, the 12-month price target for Molina Healthcare stock ranges from a low of $297 to a high of $414. The average analyst price target of $363.81 forecasts a 22.47% increase in the stock price over the next year.
Price Target: $363.81 (+22.47%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 5 | 5 | 5 | 6 |
| Hold | 6 | 8 | 7 | 9 | 9 | 9 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 14 | 15 | 16 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $351 → $347 | Hold | Maintains | $351 → $347 | +16.82% | Jun 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $364 | Buy | Initiates | $364 | +22.54% | Jun 9, 2025 |
| Barclays | Barclays | Hold Maintains $362 → $351 | Hold | Maintains | $362 → $351 | +18.16% | Jun 2, 2025 |
| Barclays | Barclays | Hold Maintains $339 → $362 | Hold | Maintains | $339 → $362 | +21.87% | Apr 25, 2025 |
| Bernstein | Bernstein | Buy Initiates $414 | Buy | Initiates | $414 | +39.37% | Apr 22, 2025 |
Financial Forecast
Revenue This Year
44.63B
from 39.16B
Increased by 13.97%
Revenue Next Year
48.13B
from 44.63B
Increased by 7.84%
EPS This Year
24.72
from 20.42
Increased by 21.07%
EPS Next Year
28.58
from 24.72
Increased by 15.62%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.1B | 51.5B | 54.9B | ||
| Avg | 44.6B | 48.1B | 51.2B | ||
| Low | 42.7B | 44.9B | 48.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.2% | 15.4% | 14.1% | ||
| Avg | 14.0% | 7.8% | 6.4% | ||
| Low | 9.2% | 0.5% | -0.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.88 | 32.55 | 37.38 | ||
| Avg | 24.72 | 28.58 | 33.03 | ||
| Low | 23.22 | 27.12 | 30.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.8% | 31.7% | 30.8% | ||
| Avg | 21.1% | 15.6% | 15.6% | ||
| Low | 13.7% | 9.7% | 5.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.